TheraRadar
← Back
Data updated: Mar 29, 2026

CARLSBAD

ImmunologyCardiovascularInfectious Disease
Generics

CARLSBAD is a generic drug manufacturer focused on Immunology, Cardiovascular, Infectious Disease.

1998
Since
8
Drugs
-
Trials
121
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ACYCLOVIR 2026-01-22
Labeling
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
DICLOFENAC SODIUM 2025-12-31
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
DICLOFENAC SODIUM 2025-11-05
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 25%
1 drugs
Cardiovascular 25%
1 drugs
Infectious Disease 25%
1 drugs
Dermatology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology